Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Finance tags : Therapeutics save search
TScan Therapeutics Announces Closing of Upsized Public Offering
Published: 2024-04-19 (Crawled : 14:00) - globenewswire.com
TCRX | News 0 d | $6.79 -1.88% -1.91% 280K
|
Professional, Scientific, and T...
|
| O: 1.04%
H: 4.55%
C: 0.0%
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: -0.35%
H: 1.39%
C: 0.33%
offering therapeutics
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s Disease
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
CERE | $42.15 0.02% 0.02% 810K
|
Finance
|
| O: 0.78%
H: 0.0%
C: 0.0%
disease positive for topline parkinson’s trial therapeutics results living
TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering
Published: 2024-04-17 (Crawled : 05:00) - globenewswire.com
TCRX | News 0 d | $6.79 -1.88% -1.91% 280K
|
Professional, Scientific, and T...
|
| O: -2.15%
H: 1.24%
C: -7.15%
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: -0.14%
H: 0.0%
C: 0.0%
million offering therapeutics
TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
Published: 2024-04-16 (Crawled : 20:00) - globenewswire.com
TCRX | News 0 d | $6.79 -1.88% -1.91% 280K
|
Professional, Scientific, and T...
|
| O: -2.15%
H: 1.24%
C: -7.15%
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: -0.14%
H: 0.0%
C: 0.0%
million offering therapeutics
Cullinan Therapeutics Announces Oversubscribed $280 million Private Placement
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
CGEM | $15.66 -13.29% -15.33% 1.2M
|
|
| O: 15.52%
H: 3.77%
C: -12.83%
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: 2.98%
H: 0.0%
C: 0.0%
million therapeutics
Contineum Therapeutics Announces Pricing of Initial Public Offering - April 05, 2024
Published: 2024-04-05 (Crawled : 09:00) - biospace.com/
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: -2.11%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
offering therapeutics
Contineum Therapeutics Announces Pricing of Initial Public Offering
Published: 2024-04-05 (Crawled : 01:00) - globenewswire.com
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: -2.11%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
offering therapeutics
Alterome Therapeutics Raises $132 Million in Series B Financing Led by Goldman Sachs Alternatives
Published: 2024-04-03 (Crawled : 11:00) - biospace.com/
GS | $404.0 0.22% 0.0% 2.8M
|
Finance
|
| O: 0.21%
H: 1.37%
C: 0.73%
million series therapeutics
Delisting of Securities of Latch, Inc.; Eloxx Pharmaceuticals, Inc.; Collective Audience, Inc. (f.k.a., ABRIC SPAC I); SeqLL Inc.; Nemaura Medical Inc.; LumiraDx Limited; Cemtrex Inc.; COMSovereign Holding Corp.; Global System Dynamics; Arrival; Nubia Brand International Corp.; The Alkaline Water Company Inc.; DMK Pharmaceuticals Corporation; MedAvail Holdings, Inc.; InVivo Therapeutics Holdings Corp.; and ADDvantage Technologies Group, Inc. from The Nasdaq Stock Market
Published: 2024-03-20 (Crawled : 20:00) - globenewswire.com
COMS | $0.2595 37.35% 720
|
Manufacturing
|
| O: -2.27%
H: 27.46%
C: 15.87%
WTER | $0.0015 14185.71% 640
|
Consumer Non-Durables
|
| O: 0.0%
H: 614.29%
C: 0.0%
NDAQ | $60.35 0.47% 0.46% 3.1M
|
Finance
|
| O: 0.46%
H: 3.09%
C: 1.11%
CETX | $3.06 -3.56% 2.7K
|
Electronic Technology
|
| O: 0.22%
H: 1.85%
C: -2.22%
water company international spac pharmaceuticals global system medical therapeutics market
Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
Published: 2024-03-18 (Crawled : 15:30) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: -6.06%
H: 10.32%
C: 3.23%
RFL 4 | $1.76 2.92% 0.0% 26K
|
Finance
|
| O: -1.16%
H: 3.51%
C: -0.58%
business year update therapeutics financial results
Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Published: 2024-03-08 (Crawled : 21:00) - globenewswire.com
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
| Email alert
Add to watchlist
AKRO | $20.76 1.22% 1.2% 790K
|
Health Technology
| Email alert
Add to watchlist
offering therapeutics
Akero Therapeutics Announces Pricing of Public Offering of Common Stock - March 06, 2024
Published: 2024-03-06 (Crawled : 12:00) - biospace.com/
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: -2.65%
H: 1.36%
C: -1.28%
AKRO | $20.76 1.22% 1.2% 790K
|
Health Technology
|
| O: 2.23%
H: 3.85%
C: -3.85%
offering therapeutics
Akero Therapeutics Announces Pricing of Public Offering of Common Stock
Published: 2024-03-06 (Crawled : 03:00) - globenewswire.com
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: -2.65%
H: 1.36%
C: -1.28%
AKRO | $20.76 1.22% 1.2% 790K
|
Health Technology
|
| O: 2.23%
H: 3.85%
C: -3.85%
offering therapeutics
Viking Therapeutics Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Published: 2024-03-04 (Crawled : 22:00) - prnewswire.com
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: -0.94%
H: 2.19%
C: -0.07%
VKTX | $63.38 -2.0% -2.04% 3M
|
Health Technology
|
| O: -1.47%
H: 3.24%
C: -2.33%
LGND | $72.59 0.1% 0.1% 140K
|
Health Technology
|
| O: -0.75%
H: 1.55%
C: -2.26%
offering therapeutics
Akero Therapeutics Announces Proposed Public Offering of Common Stock
Published: 2024-03-04 (Crawled : 21:00) - globenewswire.com
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: -0.94%
H: 2.19%
C: -0.07%
AKRO | $20.76 1.22% 1.2% 790K
|
Health Technology
|
| O: -1.03%
H: 1.95%
C: -0.75%
offering therapeutics
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
Published: 2024-02-29 (Crawled : 02:00) - prnewswire.com
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: 0.51%
H: 0.17%
C: -0.52%
VKTX | $63.38 -2.0% -2.04% 3M
|
Health Technology
|
| O: -4.5%
H: 3.38%
C: -14.63%
LGND | $72.59 0.1% 0.1% 140K
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: -6.71%
million offering therapeutics
Kyverna Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Published: 2024-02-12 (Crawled : 22:00) - prnewswire.com
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: -1.16%
H: 0.0%
C: -2.2%
offering therapeutics
Kyverna Therapeutics Announces Pricing of Upsized Initial Public Offering
Published: 2024-02-08 (Crawled : 04:00) - prnewswire.com
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: -0.37%
H: 0.64%
C: -0.04%
offering therapeutics
Silence Therapeutics Announces Oversubscribed $120 Million Private Placement
Published: 2024-02-05 (Crawled : 14:00) - biospace.com/
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: -0.79%
H: 0.0%
C: -0.8%
SLN | $22.75 3.32% 3.21% 310K
|
Health Technology
|
| O: 1.44%
H: 1.28%
C: -5.22%
million therapeutics
CEREVEL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cerevel Therapeutics - CERE
Published: 2024-01-26 (Crawled : 00:20) - prnewswire.com
TGH | $49.99 0.0% 1.2M
|
Finance
| Email alert
Add to watchlist
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
alert therapeutics
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.